Medicinal Determination of Abacavir Sulfate Sulfate, Abarelix, and Abiraterone Acetate
These substances, Abacavir Sulfate, Abarelix, and Abiraterone Acetate, each possess unique chemical organizations leading to their varying pharmacological actions. Abacavir Sulfate, a AMETANTRONE 64862-96-0 nucleoside reverse transcriptase inhibitor, is readily detected via its molecular formula – C14H15N6O4·H2SO4 – and characteristic radiant properties observed in techniques such as mass spectrometry and infrared assessment. Abarelix, a gonadotropin-releasing hormone (GnRH) receptor blocker, presents with a complex peptide sequence, typically requiring amino acid sequencing and peptide mapping for complete identification. Finally, Abiraterone Acetate, a CYP17 inhibitor utilized in prostate cancer treatment, can be verified through its particular mass and fragmentation patterns acquired through gas chromatography-mass spectrometry (GC-MS) alongside nuclear magnetic resonance (NMR) spectroscopic data, ensuring its correct chemical characterization.
Product: Abacavir Sulfate (CAS 188062-50-2) & Connected Substances
Explore the extensive listing detailing Abacavir Sulfate, identified by CAS number 188062-50-2, and a variety of related materials. The offering includes various qualities to meet specific research and manufacturing needs. You'll detailed information including analytical information and existing packaging options. Besides, examine the selection of structurally akin compounds that might be useful in the latest project. The listing is structured to assist streamlined sourcing of high-quality research reagents.
Drug Index: Abarelix and Abirateron Acetate Registry Numbers
For chemists and medicinal professionals requiring precise drug identification, correct CAS codes are crucial. Specifically, abarelix, a gonadotropin-releasing-releasing hormone agonist used in managing prostate cancer, is assigned the CAS code 65572-21-8. Furthermore, abiraterone acetate, a powerful drug in metastatic tumors, carries the Chemical Abstract Service number 389292-17-3. Meticulous documentation and confirmation of these CAS codes are imperative to guarantee accurate substance identification and following operations. Such codes are publicly obtainable through various chemical databases. Always refer recognized data for the most data.
Pharmaceutical Ingredients: Abacavir Sodium Sulfate, Abarelix, Abiraterone Acetate , Registry Numbers
The determination of essential pharmaceutical compounds often relies on precise chemical references. Specifically, this piece quickly examines three notable examples: Abacavir, a drug reverse transcriptase inhibitor; Abarelix, a hormone antagonist; and Abiraterone, utilized in malignant treatment. These substance is linked with a unique Chemical Abstracts Service number, providing a consistent method for tracking details and ensuring accurate exchange within the pharmaceutical community. Refer the respective repositories for detailed entries and associated data.
CAS Registry Number Database: Information for Abacavir Sulfate, Abarelix, Abiraterone Acetate
The comprehensive Chemical Abstracts Service (CAS) number is an essential resource for chemists and manufacturing professionals alike. This piece briefly outlines information pertaining to three key therapeutic compounds: Abacavir Sulfate, a medication used to combat HIV; Abarelix Acetate, a antagonist used in prostate cancer; and Abiraterone Acetate Salt, a effective copyright biosynthesis inhibitor administered in the treatment of metastatic prostate cancer. Locating the accurate CAS number for each substance allows for unambiguous identification and facilitates precise scientific searching. These distinct identifiers are vital for compound integrity and consistent documentation across the field.
Utilizing API Chemical Data: Compound Determination with CAS Numbers
Accurate compound identification is paramount in the chemical industry, and API substance data provides a robust solution. In particular, CAS numbers act as individual identifiers for substance entities, enabling easy integration with databases and platforms. Such approach not only enhances data accuracy but also simplifies procedures related to analysis, acquisition, and regulatory reporting. Moreover, accessing this information via an Application Programming Interface facilitates efficiency and lessens the risk for manual error.